Dr. Kenneth R. Nakazawa, MD

Dr. Nakazawa practices at Long Island Jewish Medical Center in New Hyde Park, New York.

Dr. Nakazawa's NPI, 1447754593, was assigned on March 22, 2018. Dr. Nakazawa graduated from Icahn School Of Medicine At Mount Sinai in 2018. Dr. Nakazawa holds New York license 303014.

Dr. Nakazawa's primary practice is Long Island Jewish Medical Center, at 27005 76th Ave, New Hyde Park, NY 11040 in Nassau County. The practice phone is (516) 876-6000.

Dr. Nakazawa's primary practice is Long Island Jewish Medical Center in New Hyde Park, New York. Dr. Nakazawa is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Nakazawa to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nakazawa practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Nakazawa's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Nakazawa is licensed in New York.

CMS data shows 735 Medicare services from Dr. Nakazawa across 14 procedure codes in 2024, for 208 Medicare patients. Medicare paid $78,759 for them.

CMS counts 208 Medicare patients who saw Dr. Nakazawa in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nakazawa's median patient age at 72, with 44% women.

In 2023, Dr. Nakazawa wrote 13 Medicare Part D claims. They cover 1 drug, with $218 in total drug cost. In 2022, CMS named 50 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Nakazawa for performance year 2024, reported through an alternative payment model (APM). Dr. Nakazawa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of removal of tissue by Dr. Nakazawa, more than 70% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Nakazawa, published from 2014 to 2021. 2020 was the busiest year, with 3. The most frequent topics are Macrophages, Aortic Aneurysm, Abdominal and Blood Vessel Prosthesis Implantation. Dr. Nakazawa has published most often in Ann Vasc Surg. Dr. Nakazawa's most frequent co-authors are Peter L. Faries, MD, Rami Odeh Tadros, MD and Ageliki Angela George Vouyouka, MD.

CMS Open Payments shows 122 general payments to Dr. Nakazawa from 18 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Medtronic, Inc. paid the most, $12,426.

Dr. Nakazawa graduated from Icahn School Of Medicine At Mount Sinai in 2018.